DE69527804D1 - Verfahren zum einleiten einer immunantwort bei einem einen tag alten tier - Google Patents

Verfahren zum einleiten einer immunantwort bei einem einen tag alten tier

Info

Publication number
DE69527804D1
DE69527804D1 DE69527804T DE69527804T DE69527804D1 DE 69527804 D1 DE69527804 D1 DE 69527804D1 DE 69527804 T DE69527804 T DE 69527804T DE 69527804 T DE69527804 T DE 69527804T DE 69527804 D1 DE69527804 D1 DE 69527804D1
Authority
DE
Germany
Prior art keywords
initiating
immune response
day old
old animal
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527804T
Other languages
English (en)
Other versions
DE69527804T2 (de
Inventor
Daryll A Emery
Darren E Straub
Richard Huisinga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Willmar Poultry Co Inc
Original Assignee
Willmar Poultry Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Willmar Poultry Co Inc filed Critical Willmar Poultry Co Inc
Publication of DE69527804D1 publication Critical patent/DE69527804D1/de
Application granted granted Critical
Publication of DE69527804T2 publication Critical patent/DE69527804T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE69527804T 1994-07-07 1995-02-02 Verfahren zum einleiten einer immunantwort bei einem einen tag alten tier Expired - Lifetime DE69527804T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/272,116 US5538733A (en) 1994-07-07 1994-07-07 Method of priming an immune response in a one-day old animal
PCT/US1995/001304 WO1996001620A1 (en) 1994-07-07 1995-02-02 Method of priming an immune response in a one-day old animal

Publications (2)

Publication Number Publication Date
DE69527804D1 true DE69527804D1 (de) 2002-09-19
DE69527804T2 DE69527804T2 (de) 2003-05-08

Family

ID=23038473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527804T Expired - Lifetime DE69527804T2 (de) 1994-07-07 1995-02-02 Verfahren zum einleiten einer immunantwort bei einem einen tag alten tier

Country Status (8)

Country Link
US (2) US5538733A (de)
EP (1) EP0804164B8 (de)
AU (1) AU1738795A (de)
CA (1) CA2194448C (de)
DE (1) DE69527804T2 (de)
DK (1) DK0804164T3 (de)
ES (1) ES2181798T3 (de)
WO (1) WO1996001620A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
EP0749321B1 (de) * 1994-02-09 2007-01-24 Epitopix LLC Aktive immunisierung gegen ein siderophores rezeptorprotein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
DE69632235T2 (de) * 1995-10-18 2004-08-26 Akzo Nobel N.V. Newcastle-Krankheitsvirus-Kombinationsimpfstoff
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
PL343432A1 (en) * 1998-03-02 2001-08-13 Applied Vaccine Technologies C Methods and devices for modulating the immune response
US6506385B1 (en) 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US6342231B1 (en) * 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6682754B2 (en) * 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US7138127B1 (en) 2000-01-19 2006-11-21 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US6641820B1 (en) * 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US6500436B2 (en) 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
ATE474854T1 (de) * 2000-01-27 2010-08-15 Medimmune Llc Rsv neutralisierende antikörper mit sehr hohen affinität
CA2401652A1 (en) 2000-03-01 2001-09-07 Medimmune, Inc. High potency recombinant antibodies and method for producing them
EP1276499A2 (de) * 2000-04-25 2003-01-22 Wyeth Impstoff gegen protozoen myoenzephalitis vor pferden
AU2001261371A1 (en) * 2000-05-16 2001-11-26 New York University Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same
US20040033241A1 (en) * 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
NZ526786A (en) 2001-01-03 2006-02-24 Willmar Poultry Co Inc Methods for removal of lipopolysaccharides (LPS) from vaccines for non-human animals
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
WO2004093903A2 (en) * 2003-04-18 2004-11-04 The Brigham And Women's Hospital, Inc. Methods and compositions for immunomodulation using cd1 antigens
ES2395022T3 (es) 2003-09-19 2013-02-07 Epitopix, Llc Polipéptidos de Campylobacter y sus métodos de uso
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
WO2005123120A1 (en) * 2004-06-16 2005-12-29 Smart Drug Systems Inc. Sustained release vaccine composition
WO2006026373A1 (en) 2004-08-25 2006-03-09 Epitopix, Llc Fusobacterium polypeptides and methods of use
EP1812068A4 (de) * 2004-10-29 2010-06-09 Medimmune Inc Verfahren zur prävention und behandlung von rsv-infektionen und verwandten leiden
EP2431382A1 (de) * 2005-01-21 2012-03-21 Epitopix, LLC Yersinia ssp., Polypeptide und Verwendungsverfahren
ES2586125T3 (es) 2005-02-14 2016-10-11 Epitopix, Llc Polipéptidos de Staphylococcus aureus y métodos de uso
ES2804472T3 (es) 2005-12-13 2021-02-08 Harvard College Estructuras para trasplante celular
WO2008054725A2 (en) * 2006-10-31 2008-05-08 Surmodics Pharmaceuticals, Inc. Spheronized polymer particles
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
CN101903035A (zh) * 2007-10-23 2010-12-01 阿勒根公司 使用经修饰的梭菌毒素治疗慢性神经源性炎症的方法
US8114276B2 (en) 2007-10-24 2012-02-14 Baxter International Inc. Personal hemodialysis system
EP2254602B1 (de) 2008-02-13 2018-11-21 President and Fellows of Harvard College Kontinuierliche zellprogrammiervorrichtungen
MX339461B (es) 2009-03-23 2016-05-27 Epitopix Llc Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
US11202759B2 (en) 2010-10-06 2021-12-21 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
ES2773895T3 (es) 2012-04-16 2020-07-15 Harvard College Composiciones de sílice mesoporosa para modular las respuestas inmunitarias
US10100093B2 (en) 2013-12-31 2018-10-16 Epitopix Llc Polypeptides and immunizing compositions containing Burkholderia polypeptides and methods of use
JP7348708B2 (ja) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 組み合わせワクチン装置および癌細胞を殺滅する方法
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
JP7094533B2 (ja) 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
WO2017011340A2 (en) 2015-07-10 2017-01-19 Epitopix, Llc. Proteins and immunizing compositions containing klebsiella proteins and methods of use
BR112018009319A8 (pt) 2015-11-09 2019-02-26 Epitopix Llc polipeptídeos de fusobacterium e métodos de uso
CN115531609A (zh) 2016-02-06 2022-12-30 哈佛学院校长同事会 重塑造血巢以重建免疫
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
AU2017295704B2 (en) 2016-07-13 2023-07-13 President And Fellows Of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
JP7183168B2 (ja) 2017-02-10 2022-12-05 エピトピックス， エルエルシー タンパク質、及びＰａｓｔｅｕｒｅｌｌａタンパク質を含有する免疫化組成物、ならびに使用方法
EP3743105A2 (de) 2018-01-25 2020-12-02 Epitopix, LLC Manipulierte proteine und verfahren zur verwendung
CA3236874A1 (en) 2021-10-29 2023-05-04 Vaxxinova Us, Inc. Methods and compositions for preventing infection

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
US4756907A (en) * 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4326523A (en) * 1980-08-25 1982-04-27 International Minerals & Chemical Corp. Method of supplying micronutrients to animals
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4863735A (en) * 1985-02-19 1989-09-05 Massachusetts Institute Of Technology Biodegradable polymeric drug delivery system with adjuvant activity
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
US4732155A (en) * 1985-08-27 1988-03-22 The Children's Medical Center Corporation Implantable chemoattractant system
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5026365A (en) * 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
US5015476A (en) * 1989-08-11 1991-05-14 Paravax, Inc. Immunization implant and method
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens
US5420253A (en) * 1993-09-09 1995-05-30 Willmar Poultry Company, Inc. Method for purifying egg yolk immunoglobulins
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal

Also Published As

Publication number Publication date
CA2194448C (en) 2010-03-23
EP0804164B8 (de) 2003-01-15
ES2181798T3 (es) 2003-03-01
DE69527804T2 (de) 2003-05-08
WO1996001620A1 (en) 1996-01-25
EP0804164B1 (de) 2002-08-14
DK0804164T3 (da) 2002-11-04
EP0804164A2 (de) 1997-11-05
US5906826A (en) 1999-05-25
CA2194448A1 (en) 1996-01-25
AU1738795A (en) 1996-02-09
EP0804164A4 (de) 1998-08-05
US5538733A (en) 1996-07-23

Similar Documents

Publication Publication Date Title
DE69527804D1 (de) Verfahren zum einleiten einer immunantwort bei einem einen tag alten tier
DE69621231D1 (de) Verfahren zum ernten von landwirtschaftlichen produkten
DE69634302D1 (de) Verfahren zum befestigen von gegenständen auf eine oberfläche aus karton
DE69116577D1 (de) Verfahren zum starten einer hydraulisch-betaetigten, elektronisch-gesteuerten einspritzeinheit
DE60023106D1 (de) Verfahren zum Anpassen von Tierfutter an Kundenwünsche
DE69233054D1 (de) Verfahren zum gruppieren einer grossen Dokumentsammlung
DE69209853D1 (de) Verfahren zum richten geschleppter feldgeschütze
ATA213083A (de) Verfahren zum kontinuierlichen herstellen von gegenständen aus einem folienumhüllten kern
DE69625894D1 (de) Verfahren zum verbinden von hohlplatten aus kunststoffharz
DE69535420D1 (de) Verfahren zum automatischen Melken von Tieren
DE69533430D1 (de) Verfahren zum automatischen Melken von Tieren
DE69132009D1 (de) Verfahren zum ziehen von einkristallen
DE69217228D1 (de) Verfahren zum aufstellen von multi-objekt-bedingungen in dateien
DE68916795D1 (de) Verfahren zur alkylierung von benzol in einem bewegtbett.
ATA900292A (de) Verfahren zum herstellen einer verschleissarmen schutzschicht auf einem bauteil
DE69124808D1 (de) Verfahren zur verbindung von fachwerkbindern mit nagelplatten
DE69521696D1 (de) Verfahren zum melken von tieren
DE69306782D1 (de) Verfahren zum verbinden von perfluorelastomeren
DE69102268D1 (de) Verfahren zum verlegen von rohrförmigen leitungen.
DE69506490D1 (de) Verfahren zum Anbringen von Anhänge-Etiketten an Gegenständen
DE59306040D1 (de) Verfahren zum reinigen von glycerinwasser
ATE223838T1 (de) Verfahren zum aufbringen von dehnbaren etiketten
DE69218990D1 (de) Ein Verfahren zum Auslesen von Signalen aus einer Festkörper-Bildaufnahmevorrichtung
DE69711206D1 (de) Verfahren zum verhindern von pflanzenschäden durch pflanzenfressende insekten
DE69409559D1 (de) Verfahren zum Eingiessen von einem trennbaren unteren Endanschlag auf einen verdeckten Reissverschluss

Legal Events

Date Code Title Description
8364 No opposition during term of opposition